To Get Full Access :

Sofdra

Sofdra is a topical anticholinergic gel for adults and children aged 9 and up suffering from underarm excessive sweating (primary axillary hyperhidrosis). Applied at bedtime, it helps reduce sweat production by blocking signals to sweat glands

The information outlined in the molecule details section below would help you evaluate Para IV filing opportunities early to secure a first-to-file advantage.

Molecule Details :

  • Molecule Name :

    Sofpironium
  • Innovator :

    BOTANIX SB INC
  • Approval Date :

    18-Jun-24
  • NCE-1 Date :

    18-Jun-28
  • NCE Date :

    18-Jun-29
  • Dosage Form :

    Metered Gel Topical
  • Strength :

    EQ 12.45% BASE (EQ 72MG BASE/ACTUATION)
  • Therapeutic Category :

    Antiperspirant
  • Revenue ($M) :

    NA

Year-wise Projected Sales ($M) :

  • 2025 :

    NA
  • 2026 :

    NA
  • 2027 :

    NA
  • 2028 :

    NA
  • 2029 :

    NA
  • 2030 :

    NA
  • 2031 :

    NA
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.

Why Partner With Us

Login With

For full access Sign-up / Sign-in using below Methods:

By continuing, you agree to our Terms & Conditions and Privacy Policy. You can review them anytime.

Are you sure want to logout from NCE Grid?